Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (143K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (183)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Morris, M. C.
Right arrow Articles by Divita, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, M. C.
Right arrow Articles by Divita, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 25, Issue 14 2730-2736, Copyright © 1997 by Oxford University Press

ARTICLES

A new peptide vector for efficient delivery of oligonucleotides into mammalian cells

MC Morris, P Vidal, L Chaloin, F Heitz and G Divita
Centre de Recherches de Biochimie Macromoleculaire, URS-155 CNRS, BP 5051, 1919 Route de Mende, 34033 Montpellier Cedex 1, France.

The development of antisense and gene therapy has focused mainly on improving methods for oligonucleotide and gene delivery into cells. In the present work, we describe a potent new strategy for oligonucleotide delivery based on the use of a short peptide vector, termed MPG (27 residues), which contains a hydrophobic domain derived from the fusion sequence of HIV gp41 and a hydrophilic domain derived from the nuclear localization sequence of SV40 T-antigen. The formation of peptide vector/oligonucleotide complexes was investigated by measuring changes in intrinsic tryptophan fluorescence of peptide and of mansyl-labelled oligonucleotides. MPG exhibits relatively high affinity for both single- and double-stranded DNA in a nanomolar range. Based on both intrinsic and extrinsic fluorescence titrations, it appears that the main binding between MPG and oligonucleotides occurs through electrostatic interactions, which involve the basic-residues of the peptide vector. Further peptide/peptide interactions also occur, leading to a higher MPG/oligonucleotide ratio (in the region of 20/1), which suggests that oligonucleotides are most likely coated with several molecules of MPG. Premixed complexes of peptide vector with single or double stranded oligonucleotides are delivered into cultured mammalian cells in less than 1 h with relatively high efficiency (90%). This new strategy of oligonucleotide delivery into cultured cells based on a peptide vector offers several advantages compared to other commonly used approaches of delivery including efficiency, stability and absence of cytotoxicity. The interaction with MPG strongly increases both the stability of the oligonucleotide to nuclease and crossing of the plasma membrane. The mechanism of cell delivery of oligonucleotides by MPG does not follow the endosomal pathway, which explains the rapid and efficient delivery of oligonucleotides in the nucleus. As such, we propose this peptide vector as a powerful tool for potential development in gene and antisense therapy.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
L. Crombez, M. C. Morris, S. Dufort, G. Aldrian-Herrada, Q. Nguyen, G. Mc Master, J.-L. Coll, F. Heitz, and G. Divita
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth
Nucleic Acids Res., August 1, 2009; 37(14): 4559 - 4569.
[Abstract] [Full Text] [PDF]

Home page
 Bioscience HorizonsHome page
V. Sebbage
Cell-penetrating peptides and their therapeutic applications
Bioscience Horizons, March 1, 2009; 2(1): 64 - 72.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
E. R. Gilbert, E. A. Wong, and K. E. Webb Jr.
BOARD-INVITED REVIEW: Peptide absorption and utilization: Implications for animal nutrition and health
J Anim Sci, September 1, 2008; 86(9): 2135 - 2155.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. C. Morris, E. Gros, G. Aldrian-Herrada, M. Choob, J. Archdeacon, F. Heitz, and G. Divita
A non-covalent peptide-based carrier for in vivo delivery of DNA mimics
Nucleic Acids Res., April 1, 2007; 35(7): e49 - e49.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Veldhoen, S. D. Laufer, A. Trampe, and T. Restle
Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect
Nucleic Acids Res., December 2, 2006; 34(22): 6561 - 6573.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
M. S. WEINBERG, L. M. VILLENEUVE, A. EHSANI, M. AMARZGUIOUI, L. AAGAARD, Z.-X. CHEN, A. D. RIGGS, J. J. ROSSI, and K. V. MORRIS
The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells
RNA, February 1, 2006; 12(2): 256 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. J. Turner, A. A. Arzumanov, and M. J. Gait
Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides
Nucleic Acids Res., January 7, 2005; 33(1): 27 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Labialle, G. Dayan, L. Gayet, D. Rigal, J. Gambrelle, and L. G. Baggetto
New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein
Nucleic Acids Res., July 22, 2004; 32(13): 3864 - 3876.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
F. Simeoni, M. C. Morris, F. Heitz, and G. Divita
Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells
Nucleic Acids Res., June 1, 2003; 31(11): 2717 - 2724.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. M. W. van Rossenberg, K. M. Sliedregt-Bol, N. J. Meeuwenoord, T. J. C. van Berkel, J. H. van Boom, G. A. van der Marel, and E. A. L. Biessen
Targeted Lysosome Disruptive Elements for Improvement of Parenchymal Liver Cell-specific Gene Delivery
J. Biol. Chem., November 22, 2002; 277(48): 45803 - 45810.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. L. McKenzie, K. Y. Kwok, and K. G. Rice
A Potent New Class of Reductively Activated Peptide Gene Delivery Agents
J. Biol. Chem., March 31, 2000; 275(14): 9970 - 9977.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
Y. Aubert, S. Bourgerie, L. Meunier, R. Mayer, A.-C. Roche, M. Monsigny, N. T. Thuong, and U. Asseline
Optimized synthesis of phosphorothioate oligodeoxyribonucleotides substituted with a 5'-protected thiol function and a 3'-amino group
Nucleic Acids Res., February 1, 2000; 28(3): 818 - 825.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. Liu, J. Ou, K. Saku, S. Jimi, D. P. Via, J. T. Sparrow, B. Zhang, H. J. Pownall, L. C. Smith, and K. Arakawa
Efficient Nuclear Delivery of Antisense Oligodeoxynucleotides and Selective Inhibition of CETP Expression by Apo E Peptide in a Human CETP–Stably Transfected CHO Cell Line
Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2207 - 2213.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. C. Morris, V. Robert-Hebmann, L. Chaloin, J. Mery, F. Heitz, C. Devaux, R. S. Goody, and G. Divita
A New Potent HIV-1 Reverse Transcriptase Inhibitor. A SYNTHETIC PEPTIDE DERIVED FROM THE INTERFACE SUBUNIT DOMAINS
J. Biol. Chem., August 27, 1999; 274(35): 24941 - 24946.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.